Telomir Pharmaceuticals Inc. Common Stock

TELO | NASDAQ

$1.25

+$0.01 (+0.81%)

Sep 22, 2026, 1:09 PM ET · Market open

Fiscal Year Period Ending	FY 2025 Dec 30, 2025	FY 2024 Dec 30, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022	FY 2021 Dec 30, 2021
Cash & Equivalents	7.29M	1.27M	1.23K	1.42K	n/a
Short-Term Investments	n/a	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	n/a	n/a	55K
Other Long-Term Assets	n/a	n/a	4.34M	n/a	n/a
Receivables	n/a	n/a	130K	n/a	n/a
Inventory	n/a	n/a	n/a	n/a	n/a
Other Current Assets	0	0	303.28K	47.31K	n/a
Total Current Assets	7.34M	1.32M	435.23K	48.73K	n/a
Property-Plant & Equipment	n/a	n/a	n/a	n/a	n/a
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	n/a	n/a	4.34M	n/a	55K
Total Assets	7.34M	1.32M	4.77M	48.73K	55K
Account Payables	536.77K	587.54K	707.19K	404.22K	18.74K
Deferred Revenue	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	473.75K	93.43K	101K	581.79K	n/a
Other Current Liabilities	n/a	0	527.38K	581.79K	119.4K
Total Current Liabilities	1.43M	680.97K	1.34M	986.01K	138.13K
Long-Term Debt	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	n/a	0	n/a	0	n/a
Total Long-Term Liabilities	n/a	0	n/a	0	n/a
Total Liabilities	1.43M	680.97K	1.34M	986.01K	138.13K
Total Debt	473.75K	93.43K	101K	581.79K	n/a
Book Value	5.91M	643.04K	3.44M	-937.28K	-83.13K
Book Value Per Share	0.19	0.02	0.12	-0.03	0
Common Stock	n/a	n/a	n/a	n/a	n/a
Retained Earnings	-41.01M	-30.6M	-14.06M	-992.28K	-138.13K
Comprehensive Income	n/a	n/a	n/a	n/a	n/a
Shareholders Equity	5.91M	643.04K	3.44M	-937.28K	-83.13K
Total Investments	n/a	n/a	n/a	n/a	55K